EC Number   |
Inhibitors |
Structure  |
|---|
   3.4.15.1 | more |
enzyme is not affected by addition of 0.1-1.0 mM CaCl2, Mn2Cl2, MgCl2 or 0.1 mM ZnCl2 |
 |
| 3.4.15.1 | more |
the presence of verticione, verticine, peimisine may be responsible, at least in part, for the antihypertensive action of the bulbs of Fritillaria ussuriensis |
|
| 3.4.15.1 | more |
synthetic peptides derived from human collagen XVIII hinge domain with sequences similar to bradykinin potentiating peptides from snake venom |
|
| 3.4.15.1 | more |
isolation of angiotensin converting enzyme (ACE) inhibitory flavonoids from Sedum sarmentosum |
|
| 3.4.15.1 | more |
hot water extract of Tamogi-take mushroom, IC50: 6 mg/ml |
|
| 3.4.15.1 | more |
hot water extract of Tamogi-take mushroom, antihypertensive effect in spontaneously hypertensive rats by oral administration |
|
| 3.4.15.1 | more |
inhibitory peptide from Alaska pollack (Theragra chalcogramma) frame protein hydrolysate |
|
| 3.4.15.1 | more |
inhibitory peptides from in vitro pepsin-pancreatin digestion of soy protein |
|
| 3.4.15.1 | more |
compounds from Epilobium angustifolium inhibit. Taking into account the role of these peptidase in prostate diseases, the results may partly support and explain the use of Epilobium extracts in folk medicine |
|
| 3.4.15.1 | more |
inhibition by food extract solution from garlic, buckwheat, mushroom, soy sauce, Tokuho A, Tokuho B |
|
